Post by: JaMmY1 Thursday, 11/07/19 10:02:08 PM
Facts -vs- Speculation
I've attempted to separate (what I consider) Facts, from Speculation.
Facts = what IS. Speculation = what CAN BE
Facts are real. Although they can be manipulated, basic due diligence will sustain and confirm them.
You will not find any new developments or amazing discoveries in this post.. But... these facts describing what already IS reveals VYST's strong foundation. This is a long post with 35 listed items, so you will naturally read through them fairly quickly. However, every single one has a huge impact and deserves a little more DD when you have time.
Here's what I've gathered from corporate tweets, other VYST Longs, and multiple websites.
- - - - - - -
1. VYST paid off Millions of convertible aged debt and all 3rd party note-holders.
2. Nearly HALF the Outstanding Shares are owned by insiders and subject to Rule 144. About half of the float is locked, giving the company alternative options to reduce the OS.
3. There have been over 290 Form 4's from insider purchases, and not a single share sold in the last decade. Not a single insider sold a single share - even at the 52 week high above 15 cents.
4. CEO Steve Rotman and his family of predecessors have a long legacy of integrity and giving back to their community.
5. Dr. Matthan is an internationally renowned latex and rubber expert, and has been appointed by the Government of India as the top authority in this field. Please note that India is ranked 4th in the world - in rubber producing countries. In short: Our VYST Board Member is the Government appointed head of rubber and latex over an entire Country that is ranked 4th in World Production.
6. Dr. Stone is the Chairman of Medicine at Desert Regional Medical Center in Palm Springs, California - and Medical Director at multiple DaVita Dialysis Centers.
7. Dr. Allegra is principal of 3 hedge funds that has driven Billions of dollars in deals.
8. VYST's partner (Lien A) has a 3.2 million sq.ft. factory in Vietnam with the capability to fulfill any scale of commercial growth (1,000+ beds per day), plus the ability to ship directly to consumers anywhere in the USA for a $40 flat rate fee.
9. VYST Board Members and partners have invested over $20 Million of their own funds, putting skin in the game. Compared to common shareholders, they have substantially so much more to gain from a higher PPS, and much more to lose from a lower PPS.
10. CEO Steve Rotman has been paid in shares (no money) for 2 years of work. This CEO has no golden parachute and has more incentive for the PPS to climb than any common shareholder.
11. Rotmans has been acquired by VYST under the most favorable terms. Seasoned investors have stated that they have never seen an acquisition done on such favorable terms.
12. If Rotmans goal was to simply go public, it would have purchased a $300,000 shell, instead of eliminating about $4 Million in toxic debt and notes.
13. The 8ka filing is following the Guidance given directly from the SEC's OCA to ensure everything is filed correctly - the first time.
14. Rotmans will add over $30 Million in Revenues to VYST. In just the last 3 months (July 23,2019 - October 23, 2019), Rotmans alone brought just shy of $9 Million in revenue.
15. Rotmans has over 150 employees, with an astounding 22 year average length of employment and a solid pension fund.
16. Rotmans has all the infrastructure needed for VYST's commercial growth: Manufacturing, warehousing, staffing, shipping, trucking, financing, etc. Without this infrastructure, VYST would not be able to commercialize its game changing technology.
17. VYST has multiple international and domestic patents to protect its technology that can improve 40,000 items across multiple industries.
18. Latex allergies are on the rise, and especially damaging to health care professionals who deal with them heavily on an everyday basis. Alternatives can be costly, less comfortable, or less efficient. Vytex offers a solution.
19. Vytex is superior to synthetic latex: Removes the proteins, becomes virtually allergy free, eliminates synthetic latex odor, becomes as biodegradable as an oak leaf, all while being less expensive to produce.
20. Vytex can save synthetic latex manufacturers 4 MT of latex every day that is required to start their machines. At the end of the day, the latex is trashed. Vytex can last 7 days in the machines and save the manufacturer about $25,000 per week. This ultimately saves 15% in production costs due to waste reduction. In short: Vytex offers a superior product, that is less expensive to make.
21. Vytex has no issues with disposal, due to its biodegradability. Whereas Tempurpedic mattresses (for example) has to be disposed as "toxic waste". Not only is it "toxic" for the environment, but it will cost an additional $70 to dispose of such.
22. VYST has acquired Net Suite and One World valued at over $2 Million, that improve daily operations and can easily handle the ins-and-outs of inventory expansion, commercial growth, create better reporting systems, track specific branded products, monitor new lines, new launches, etc.
23. VYST has successfully completed injection molding into soft plastics like straws, bags and bottles. Current successful injection of up to 50% Vytex into hard plastics like Lego bricks. VYST technology is growing a diverse number of applications - outside of latex - that can make a big "eco-friendly" impact on the world.
24. 250,000 Superior Vytex gloves cost about $20,000 to produce. Company is currently testing this amount of gloves with 4 facilities that spend about $60 Million a year on gloves alone. Only 4 facilities (of thousands). Only 1 product (of thousands). $60 Million per year.
25. Sonnet Sleep is a new line of 9 mattresses (hybrid & all Vytex) that is rolling out. New website is being built and the line is expected to be carried by retailers nationwide. Initial test of $100,000 worth of products have been sold and documented to identify and flush out any potential issues with the new line - before the official nationwide launch. Company said to stay tuned.
26. VYST paid for 2 individuals who were voted by shareholders to do a tour of the facilities and interview VYST admin. The 2 representatives would provide shareholders with a deeper look into company operations, capabilities and upcoming plans. This level of transparency is very rare in the OTC.
27. CEO personally guaranteed $3.5 Million in company loans, personally putting him on the hook for company liabilities if plans should fail. Quick recap: This CEO allowed himself to get paid in shares (no money), put his successful family business and impeccable family legacy on the line, AND personally guaranteed the company loans needed for this merger to take place. He then constructed the merger under the most favorable terms for shareholders, while waiting patiently for the SEC guidance to ensure that the 8ka filings are done correctly - the first time.
28. VYST is currently on the OTCQB so company info is continually updated, eliminating baseless allegations of company dilution.
29. TamiCare is currently working with VYST, and can already print 3D Vytex fabric. When the process is eventually finalized, there could be substantial savings due to no cutting labor, no cutting waste, and no excess inventory.
30. VYST's accounting team consists of: 4 CPA's, 2 accountants under them, a staff of 8+ doing in house accounting, a team of auditors, several outside consultants, and 1 hired consultant to do GAAP report on the acquisition, allocation of the assets, and a proforma. Remember this when you come across non-professionals claiming to have a better understanding of governing financial rules.
31. VYST has a contract with Centrotrade (now Corrie Maccoll) to supply Vytex around the world and currently selling Vytex to make electrical contractor gloves used on high power lines, a glue that's used for sneakers, balloons, etc.
32. The upcoming 10Q could have more revenue in this ONE QUARTER than the company's entire past DECADE combined. The term "record-breaking" would be an understatement.
33. VYST has met with various Investment Bankers in NYC and has a few potential partners. After the combined financials are released, VYST may engage them to solidify a partnership. The investment banker would be needed for a buyback and guidance through all other tasks towards their up-listing goals.
34. RxAir machines will be made in the company facility in Worcester MA. using Veteran Labor. The company is proud to manufacture in the USA, and employ our respected veterans. In addition, the filters will also be manufactured in house so as to avoid tariff issues.
35. Vystar RxAir dividend spin off will make RxAir, Inc. a publicly traded subsidiary, and contract 51% to an outside entity which will invest $3 million to $5 million in production, tooling, inventory and operations. Of the remaining 49% in VYST, they will only keep 10% and give us VYST shareholders the other 39%. VYST will announce the ex-dividend date, which will be set 60 days following the announcement.
These are some of what I consider to be factual events.
I won't bother to list the Speculation of potential mind-blowing catalysts in the pipeline, because honestly, it's just speculation.
However, I'm a happy investor simply based on the amazing facts listed above. To be a part of this company for only 2 cents per share is an amazing deal.
BUT..... IF ANY SINGLE ONE of my speculation comes to fruition, this ticker will dramatically improve the financial lives of its shareholders.
Good luck everyone,
-Jammy-
Facts -vs- Speculation
I've attempted to separate (what I consider) Facts, from Speculation.
Facts = what IS. Speculation = what CAN BE
Facts are real. Although they can be manipulated, basic due diligence will sustain and confirm them.
You will not find any new developments or amazing discoveries in this post.. But... these facts describing what already IS reveals VYST's strong foundation. This is a long post with 35 listed items, so you will naturally read through them fairly quickly. However, every single one has a huge impact and deserves a little more DD when you have time.
Here's what I've gathered from corporate tweets, other VYST Longs, and multiple websites.
- - - - - - -
1. VYST paid off Millions of convertible aged debt and all 3rd party note-holders.
2. Nearly HALF the Outstanding Shares are owned by insiders and subject to Rule 144. About half of the float is locked, giving the company alternative options to reduce the OS.
3. There have been over 290 Form 4's from insider purchases, and not a single share sold in the last decade. Not a single insider sold a single share - even at the 52 week high above 15 cents.
4. CEO Steve Rotman and his family of predecessors have a long legacy of integrity and giving back to their community.
5. Dr. Matthan is an internationally renowned latex and rubber expert, and has been appointed by the Government of India as the top authority in this field. Please note that India is ranked 4th in the world - in rubber producing countries. In short: Our VYST Board Member is the Government appointed head of rubber and latex over an entire Country that is ranked 4th in World Production.
6. Dr. Stone is the Chairman of Medicine at Desert Regional Medical Center in Palm Springs, California - and Medical Director at multiple DaVita Dialysis Centers.
7. Dr. Allegra is principal of 3 hedge funds that has driven Billions of dollars in deals.
8. VYST's partner (Lien A) has a 3.2 million sq.ft. factory in Vietnam with the capability to fulfill any scale of commercial growth (1,000+ beds per day), plus the ability to ship directly to consumers anywhere in the USA for a $40 flat rate fee.
9. VYST Board Members and partners have invested over $20 Million of their own funds, putting skin in the game. Compared to common shareholders, they have substantially so much more to gain from a higher PPS, and much more to lose from a lower PPS.
10. CEO Steve Rotman has been paid in shares (no money) for 2 years of work. This CEO has no golden parachute and has more incentive for the PPS to climb than any common shareholder.
11. Rotmans has been acquired by VYST under the most favorable terms. Seasoned investors have stated that they have never seen an acquisition done on such favorable terms.
12. If Rotmans goal was to simply go public, it would have purchased a $300,000 shell, instead of eliminating about $4 Million in toxic debt and notes.
13. The 8ka filing is following the Guidance given directly from the SEC's OCA to ensure everything is filed correctly - the first time.
14. Rotmans will add over $30 Million in Revenues to VYST. In just the last 3 months (July 23,2019 - October 23, 2019), Rotmans alone brought just shy of $9 Million in revenue.
15. Rotmans has over 150 employees, with an astounding 22 year average length of employment and a solid pension fund.
16. Rotmans has all the infrastructure needed for VYST's commercial growth: Manufacturing, warehousing, staffing, shipping, trucking, financing, etc. Without this infrastructure, VYST would not be able to commercialize its game changing technology.
17. VYST has multiple international and domestic patents to protect its technology that can improve 40,000 items across multiple industries.
18. Latex allergies are on the rise, and especially damaging to health care professionals who deal with them heavily on an everyday basis. Alternatives can be costly, less comfortable, or less efficient. Vytex offers a solution.
19. Vytex is superior to synthetic latex: Removes the proteins, becomes virtually allergy free, eliminates synthetic latex odor, becomes as biodegradable as an oak leaf, all while being less expensive to produce.
20. Vytex can save synthetic latex manufacturers 4 MT of latex every day that is required to start their machines. At the end of the day, the latex is trashed. Vytex can last 7 days in the machines and save the manufacturer about $25,000 per week. This ultimately saves 15% in production costs due to waste reduction. In short: Vytex offers a superior product, that is less expensive to make.
21. Vytex has no issues with disposal, due to its biodegradability. Whereas Tempurpedic mattresses (for example) has to be disposed as "toxic waste". Not only is it "toxic" for the environment, but it will cost an additional $70 to dispose of such.
22. VYST has acquired Net Suite and One World valued at over $2 Million, that improve daily operations and can easily handle the ins-and-outs of inventory expansion, commercial growth, create better reporting systems, track specific branded products, monitor new lines, new launches, etc.
23. VYST has successfully completed injection molding into soft plastics like straws, bags and bottles. Current successful injection of up to 50% Vytex into hard plastics like Lego bricks. VYST technology is growing a diverse number of applications - outside of latex - that can make a big "eco-friendly" impact on the world.
24. 250,000 Superior Vytex gloves cost about $20,000 to produce. Company is currently testing this amount of gloves with 4 facilities that spend about $60 Million a year on gloves alone. Only 4 facilities (of thousands). Only 1 product (of thousands). $60 Million per year.
25. Sonnet Sleep is a new line of 9 mattresses (hybrid & all Vytex) that is rolling out. New website is being built and the line is expected to be carried by retailers nationwide. Initial test of $100,000 worth of products have been sold and documented to identify and flush out any potential issues with the new line - before the official nationwide launch. Company said to stay tuned.
26. VYST paid for 2 individuals who were voted by shareholders to do a tour of the facilities and interview VYST admin. The 2 representatives would provide shareholders with a deeper look into company operations, capabilities and upcoming plans. This level of transparency is very rare in the OTC.
27. CEO personally guaranteed $3.5 Million in company loans, personally putting him on the hook for company liabilities if plans should fail. Quick recap: This CEO allowed himself to get paid in shares (no money), put his successful family business and impeccable family legacy on the line, AND personally guaranteed the company loans needed for this merger to take place. He then constructed the merger under the most favorable terms for shareholders, while waiting patiently for the SEC guidance to ensure that the 8ka filings are done correctly - the first time.
28. VYST is currently on the OTCQB so company info is continually updated, eliminating baseless allegations of company dilution.
29. TamiCare is currently working with VYST, and can already print 3D Vytex fabric. When the process is eventually finalized, there could be substantial savings due to no cutting labor, no cutting waste, and no excess inventory.
30. VYST's accounting team consists of: 4 CPA's, 2 accountants under them, a staff of 8+ doing in house accounting, a team of auditors, several outside consultants, and 1 hired consultant to do GAAP report on the acquisition, allocation of the assets, and a proforma. Remember this when you come across non-professionals claiming to have a better understanding of governing financial rules.
31. VYST has a contract with Centrotrade (now Corrie Maccoll) to supply Vytex around the world and currently selling Vytex to make electrical contractor gloves used on high power lines, a glue that's used for sneakers, balloons, etc.
32. The upcoming 10Q could have more revenue in this ONE QUARTER than the company's entire past DECADE combined. The term "record-breaking" would be an understatement.
33. VYST has met with various Investment Bankers in NYC and has a few potential partners. After the combined financials are released, VYST may engage them to solidify a partnership. The investment banker would be needed for a buyback and guidance through all other tasks towards their up-listing goals.
34. RxAir machines will be made in the company facility in Worcester MA. using Veteran Labor. The company is proud to manufacture in the USA, and employ our respected veterans. In addition, the filters will also be manufactured in house so as to avoid tariff issues.
35. Vystar RxAir dividend spin off will make RxAir, Inc. a publicly traded subsidiary, and contract 51% to an outside entity which will invest $3 million to $5 million in production, tooling, inventory and operations. Of the remaining 49% in VYST, they will only keep 10% and give us VYST shareholders the other 39%. VYST will announce the ex-dividend date, which will be set 60 days following the announcement.
These are some of what I consider to be factual events.
I won't bother to list the Speculation of potential mind-blowing catalysts in the pipeline, because honestly, it's just speculation.
However, I'm a happy investor simply based on the amazing facts listed above. To be a part of this company for only 2 cents per share is an amazing deal.
BUT..... IF ANY SINGLE ONE of my speculation comes to fruition, this ticker will dramatically improve the financial lives of its shareholders.
Good luck everyone,
-Jammy-
